Cancer suppression by systemic inactivation of p38MAPK

Oncotarget. 2017 Feb 28;8(9):14275-14276. doi: 10.18632/oncotarget.15293.

Authors

Anna Brichkina¹, Dmitry V Bulavin²

Affiliations

¹ Institute of Molecular Oncology, Philipps University, Marburg, Germany.
² Institute for Research on Cancer and Aging of Nice (IRCAN), INSERM, U1081-UMR CNRS 7284, University of Nice-Sophia Antipolis, Centre Antoine Lacassagne, Nice, France.

No abstract available

Keywords: hyaluronan; lung cancer; p38 kinase; stromal fibroblasts; tumor microenvironment.

Publication types

Editorial

MeSH terms

Animals
Antineoplastic Agents / pharmacology
Disease Models, Animal
Extracellular Matrix / metabolism
Fibroblasts / metabolism
Humans
Inflammation
Lung / metabolism
Mice
Mole Rats
Neoplasms / drug therapy
Neoplasms / enzymology*
Neoplasms / genetics*
Neoplastic Stem Cells / cytology
Rats
Tumor Microenvironment
p38 Mitogen-Activated Protein Kinases / antagonists & inhibitors*
p38 Mitogen-Activated Protein Kinases / metabolism*

Substances

Antineoplastic Agents
p38 Mitogen-Activated Protein Kinases